Post-approval studies (Phase 4)Study completedNCT00637884
What this trial is testing
A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms
Who this might be right for
Cat Induced Allergic Rhinitis
Sanofi 70